Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Zeng

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Cancer Immunology, Immunotherapy : CII|June 21, 2021
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosisRuiting Ye, Han Zeng, Zhaopei Liu, et al.
British Journal of Cancer|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpressionLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Nature Communications|October 2, 2022
CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasisPing Yang, Hong Qin, Yiyu Li, et al.
International Immunopharmacology|December 17, 2022
Effect of inactivated COVID-19 vaccination on pregnancy outcomes following frozen-thawed embryo transfer: A retrospective cohort studyJialyu Huang, Yiqi Liu, Han Zeng, et al.
Oncoimmunology|January 18, 2021
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin<sup>+</sup> cell abundanceQuan Zhou, Zewei Wang, Han Zeng, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Stromal LAG-3<sup>+</sup> cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contextureHan Zeng, Quan Zhou, Zewei Wang, et al.
ACS Applied Materials & Interfaces|September 19, 2025
Taiwan Rhinoceros Beetle-Inspired Impact-Resistant Structures as Recoverable Antireflection CoatingsBo-Han Zeng, Shang-Hsuan Lu, Hsiang-Wen Hsueh, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Intratumoral CXCL13<sup>+</sup>CD8<sup>+</sup>T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinomaSiyuan Dai, Han Zeng, Zhaopei Liu, et al.
Oncoimmunology|April 22, 2020
Tumor-infiltrating IL-17A<sup>+</sup> cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancerZewei Wang, Quan Zhou, Han Zeng, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patientsYing Xiong, Zewei Wang, Quan Zhou, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Cancer Immunology, Immunotherapy : CII|June 21, 2021
Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosisRuiting Ye, Han Zeng, Zhaopei Liu, et al.
British Journal of Cancer|May 15, 2026
Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpressionLingkai Zhang, Zhaopei Liu, Yawei Ding, et al.
Nature Communications|October 2, 2022
CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasisPing Yang, Hong Qin, Yiyu Li, et al.
International Immunopharmacology|December 17, 2022
Effect of inactivated COVID-19 vaccination on pregnancy outcomes following frozen-thawed embryo transfer: A retrospective cohort studyJialyu Huang, Yiqi Liu, Han Zeng, et al.
Oncoimmunology|January 18, 2021
Identification and validation of poor prognosis immunoevasive subtype of muscle-invasive bladder cancer with tumor-infiltrating podoplanin<sup>+</sup> cell abundanceQuan Zhou, Zewei Wang, Han Zeng, et al.
Journal for Immunotherapy of Cancer|June 17, 2020
Stromal LAG-3<sup>+</sup> cells infiltration defines poor prognosis subtype muscle-invasive bladder cancer with immunoevasive contextureHan Zeng, Quan Zhou, Zewei Wang, et al.
ACS Applied Materials & Interfaces|September 19, 2025
Taiwan Rhinoceros Beetle-Inspired Impact-Resistant Structures as Recoverable Antireflection CoatingsBo-Han Zeng, Shang-Hsuan Lu, Hsiang-Wen Hsueh, et al.
Journal for Immunotherapy of Cancer|February 16, 2021
Intratumoral CXCL13<sup>+</sup>CD8<sup>+</sup>T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinomaSiyuan Dai, Han Zeng, Zhaopei Liu, et al.
Oncoimmunology|April 22, 2020
Tumor-infiltrating IL-17A<sup>+</sup> cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancerZewei Wang, Quan Zhou, Han Zeng, et al.
Journal for Immunotherapy of Cancer|March 29, 2020
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patientsYing Xiong, Zewei Wang, Quan Zhou, et al.
Pageof 13